The American weekly magazine Science recently published a report about Poland buying F-16 fighter jets from the US. We would do well to use it for reference, in particular since a couple of Taiwan's past large purchases of military equipment from the US have invited a lot of maneuvering behind the scenes. Future arms purchases are necessary for Taiwan's national defense, but there are financial difficulties and with hints that US prices are too high there is much cause for confusion.
I believe that the people of Taiwan would appreciate the Polish model for purchase of US weapons as described below.
According to the Science report, the Polish government purchased 48 F-16 fighter jets from Lockheed Martin on April 19, to replace its aging fleet of Soviet-made MiGs -- a deal worth US$3.5 billion.
According to Polish law, military purchases from foreign companies must be offset by a package of investments put together by the seller which is equivalent to the purchase price -- the equivalent of attracting the same amount of foreign investment. This foreign capital is invested in projects from which both the foreign investor and Poland stand to profit.
Lockheed Martin was able to outlast France, the UK and Sweden during the bidding process because it showed its willingness to invest US$7.5 billion, including investments in many Polish high-tech projects. It will therefore be of great help to Polish science.
Contracts for these investments in Polish high-tech projects will be signed within the next few weeks. These contracts will include some important biotech companies, such as Bioton, a company that produces recombinant insulin, and a business and technology center in Lodz, the country's second-largest city. The Bioton investment will be worth tens of millions of dollars, helping the company register its products in other countries and enabling it to export its products. The US$300 million Lodz technology accelerator project aims to give venture capital funding and business advice to high-tech entrepreneurs.
Based on these contracts, Poland will be able to attract large amounts of capital. When the Polish science ministry solicited proposals for suitable investments from scientists, however, the results were less than ideal. Seven hundred proposals were received, but half of those were research plans that had still not yielded any results and therefore were not ready for commercial development.
In the end, the science ministry managed to present 74 investment options to Lockheed Martin. Regardless, this is a great shot in the arm for Polish science. The conclusion of the science minister, Michal Kleiber, was that "In the past, everyone suffered from insufficient budgets. Now, with US$6 billion on the table, they're all beginning to move."
The Polish experience shows us that the people in three areas need to increase their efforts: the Legislative Yuan, the technology sector and the government.
First, legislators should hurry to pass legislation. Following the spirit of the Regulations for the Prevention and Treatment of SARS (SARS
Given the amount of military purchases, this would be very helpful for the nation's growth. At the same time, it could be enormously helpful to Taiwan if the military would increase the transparency of its purchases, remove restrictions and create foreign investment.
Second, I hope that the nation's technology sector, in particular the biological and pharmaceutical technology sectors, will be able to avoid what happened in Poland -- having nothing to sell when our counterpart has the money. Strengthen R&D so that when this "military purchase reciprocity fund" come into existence, we can take the opportunity to export our bio-medical products in the same way we are now exporting our electronics products.
Third, the government has two main tasks, the first being to explain this law -- should it be passed -- to sellers, so that they understand that it is mutually beneficial and not meant to create problems for them.
The second task is that even though both government and private circles are intent on speeding up the development of biopharmaceutical products, the capital of Yunghsin Co, the nation's largest pharmaceutical company, is a mere NT$2.4 billion.
Compare this to Taiwan Semiconductor Manufacturing Co's NT$186.2 billion and United Microelectronics Corp's NT$154.7 billion. The difference is huge.
How shall domestic pharmaceutical companies be able to compete with foreign manufacturers? Government and private investors should actively direct funds from the electronics industry towards the biomedical industry, in order to quickly upgrade the biotechnological industry.
If Poland could do it, I hope Taiwan also will be able to do it.
Chen Yao-chang is director of the Stem Cell Research Center at National Health Research Institutes.
Translated by Perry Svensson
Saudi Arabian largesse is flooding Egypt’s cultural scene, but the reception is mixed. Some welcome new “cooperation” between two regional powerhouses, while others fear a hostile takeover by Riyadh. In Cairo, historically the cultural capital of the Arab world, Egyptian Minister of Culture Nevine al-Kilany recently hosted Saudi Arabian General Entertainment Authority chairman Turki al-Sheikh. The deep-pocketed al-Sheikh has emerged as a Medici-like patron for Egypt’s cultural elite, courted by Cairo’s top talent to produce a slew of forthcoming films. A new three-way agreement between al-Sheikh, Kilany and United Media Services — a multi-media conglomerate linked to state intelligence that owns much of
The US and other countries should take concrete steps to confront the threats from Beijing to avoid war, US Representative Mario Diaz-Balart said in an interview with Voice of America on March 13. The US should use “every diplomatic economic tool at our disposal to treat China as what it is... to avoid war,” Diaz-Balart said. Giving an example of what the US could do, he said that it has to be more aggressive in its military sales to Taiwan. Actions by cross-party US lawmakers in the past few years such as meeting with Taiwanese officials in Washington and Taipei, and
The Republic of China (ROC) on Taiwan has no official diplomatic allies in the EU. With the exception of the Vatican, it has no official allies in Europe at all. This does not prevent the ROC — Taiwan — from having close relations with EU member states and other European countries. The exact nature of the relationship does bear revisiting, if only to clarify what is a very complicated and sensitive idea, the details of which leave considerable room for misunderstanding, misrepresentation and disagreement. Only this week, President Tsai Ing-wen (蔡英文) received members of the European Parliament’s Delegation for Relations
Denmark’s “one China” policy more and more resembles Beijing’s “one China” principle. At least, this is how things appear. In recent interactions with the Danish state, such as applying for residency permits, a Taiwanese’s nationality would be listed as “China.” That designation occurs for a Taiwanese student coming to Denmark or a Danish citizen arriving in Denmark with, for example, their Taiwanese partner. Details of this were published on Sunday in an article in the Danish daily Berlingske written by Alexander Sjoberg and Tobias Reinwald. The pretext for this new practice is that Denmark does not recognize Taiwan as a state under